Opinion

Video

Patient Selection for Chemotherapy-Based Combination Regimens in Metastatic Prostate Cancer

Key Takeaways

  • Chemotherapy is often selected for aggressive or advanced-stage cancers requiring rapid tumor reduction.
  • Patients with specific genetic mutations may benefit more from targeted therapies than chemotherapy.
SHOW MORE

The panelist discusses how patient characteristics, disease factors, and individual health status guide the decision to include or avoid chemotherapy in combination treatments for metastatic prostate cancer, weighing potential benefits against risks and quality of life considerations.

Related Videos
Man talking with doctor, who is taking notes on a clipboard | Image Credit: © DragonImages - stock.adobe.com
Oliver Sartor, MD, is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Michael Jenson, PA-C, answers a question during a Zoom video interview
Oliver Sartor, MD, is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.